Kritoma

Discovery

Explore Topics Papers

Docs Terms Privacy

Search Kritoma

Recent searches

Searches you run from this bar will appear here.

GLP-1 receptor agonists for obesity treatment

Clinical MedicineUpdated Oct 5, 2026Version v1

Knowledge Timeline Gaps (1)Evidence (359)Community (0)

GLP-1 receptor agonists for obesity treatment — Research Evidence and Topic... | Kritoma

Evidence

Public papers linked to this topic and used as evidence for gaps, timelines, and knowledge views.

359 papers

SearchSort evidence

All359 Core251 Supporting111 Background0

Showing 241-252 of total 359 evidence records.

Open a paper to inspect abstract, source links, and topic context.

2026PubMedSupporting evidence

Exploring disparities in adherence to colorectal cancer clinical practice guidelines and associated survival outcomes: a systematic review and meta-analysis.

Gunasekaran GH; Ibrahim B; Saleem F; Shabaruddin FH

Jan 1, 2026Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

2026PubMedSupporting evidence

Systematic Review of rTMS and dTMS in Treatment-Resistant Obsessive-Compulsive Disorder: Target- and Phenotype-Specific Outcomes.

Martínez-Montero M; González-Domenech P; Romera-Gutiérrez I; Moleón-Ruiz Á; Martín-Bejarano M; Gutiérrez-Rojas L; Jiménez-Fernández S

Jan 1, 2026The Psychiatric quarterly

2026PubMedDirectly related

Multi-Database Pharmacovigilance Analysis of Gastroesophageal Reflux Disease Associated with GLP-1 Receptor Agonists: A Cross-National Signal Validation Study.

Choi JG; Gong EJ; Bang CS; Lee JJ

Jan 1, 2026Gut and liver

2026PubMedDirectly related

Patient-Reported Continuity of GLP-1 Receptor Agonist Therapy.

Chen Y; Piantek G; Zhang X; Feng Y; Yan C; Samuels JM; Rosenbloom ST; Yu D; Novak LL; Srivastava G

Jan 1, 2026Obesity science & practice

2026PubMedDirectly related

Dramatic Improvement of Treatment-Refractory Prurigo Nodularis Following Initiation of Semaglutide: A Case Report.

Fougerousse AC

Jan 1, 2026Clinical, cosmetic and investigational dermatology

2026PubMedDirectly related

Pharmacological management of obesity: Current landscape and emerging therapies.

Atal S; Agrawal C; Gupta R; Sadasivam B

Jan 1, 2026Indian journal of pharmacology

2026PubMedDirectly related

Digital Engagement and Predictors of Semaglutide Persistence and Weight Loss in Severe Obesity: 48-Week Observational Study.

Tournayre S; Bonnet JB; Anitcheou J; Faivre M; Boegner C; Jalek A; Jullien D; Le Rouzic C; Attalin V; Myzia J; Kemba Y; Sultan A; Avignon A

Jan 1, 2026Journal of medical Internet research

2026PubMedDirectly related

Pulmonary response to glucagon-like peptide-1 receptor agonist therapy in adults with cystic fibrosis-related diabetes: factors associated with improvement in FEV(1).

Mirfakhraee S; Abreu M; Singh A; Ratti GA; Finklea JD; Jain R; Abramowitz J

Jan 1, 2026Respiratory medicine

2026PubMedDirectly related

Where the Future Lies: GLP-1 Receptor Agonists as Therapeutics for Dermatologic Comorbidities.

DeCoster M; Narla S

Jan 1, 2026Clinics in dermatology

2026PubMedSupporting evidence

School-based diet and physical activity interventions and weight-related outcomes among children and adolescents in Africa: a systematic review and meta-analysis.

Onyeonu BA; Kalu FC; Igbokwe KC; Thomspon UV; Okezie FC; Taiwo AF; Iheme GO

Jan 1, 2026BMC public health

2026PubMedSupporting evidence

Effectiveness of Liraglutide in Patients With Obesity Who Are Early Non-Responders to Lifestyle Intervention: A Real-World Study.

Gilardini L; Vincenti V; Croci M; Martinelli S; Pasqualinotto L; Toja P; Cavaggioni L; Bertoli S

Jan 1, 2026Journal of obesity

2026PubMedSupporting evidence

Effectiveness of Neurological Physiotherapy Interventions in Post-stroke Motor Rehabilitation: A Systematic Review.

Ankireddypalli S; Avadhani D; Roy MS; Kumar Y; Prajapati TT; Vyas N; Jadhav RS

Jan 1, 2026Cureus

Page 21 of 30Showing 241-252 of total 359 results.

1...202122...30